BRD4 and neoplasm: Targeted inhibition of BRD4 suppresses tumour growth in breast and prostate cancer, as well as in acute myeloid leukaemia and diffuse large B-cell lymphoma (Zuber et al, 2011; Chapuy et al, 2013; Asangani et al, 2014; Shu et al, 2016).